Signaling pathway inhibitors target breast cancer stem cells in triple-negative breast cancer

Wenlong Li(Tianjin University of Traditional Chinese Medicine), Aiping Shi(First Bethune Hospital of Jilin University), Ning Xu(First Affiliated Hospital of Zhengzhou University), Xiaoli Li(Fujian Medical University), Han Lou(Harbin Medical University), Hongmei Yang(Changchun University of Chinese Medicine)
Oncology Reports
October 18, 2018
Cited by 34


Related Papers